TRASTUZUMAB
Injection for Intravenous Use ● 150mg/vial ● 440mg/vial
HOW IT WORKS?
ANKEBIO TRASTUZUMAB is a monoclonal antibody specifically designed to inhibit the proliferation of human tumor cells that overexpress HER2.
WHO IS IT FOR?
ANKEBIO Trastuzumab is for patients with HER2*-overexpressing breast or gastric cancer *HER2, human epidermal growth factor receptor 2.
ANKEBIO Trastuzumab is indicated for the treatment of patients with:
Adjuvant Breast Cancer
Metastatic Breast Cancer
Metastatic Gastric Cancer
